174 related articles for article (PubMed ID: 36965095)
21. Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm.
Wang W; Xu J; Khoury JD; Pemmaraju N; Fang H; Miranda RN; Yin CC; Hussein SE; Jia F; Tang Z; Hu S; Konopleva M; Medeiros LJ; Wang SA
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884435
[TBL] [Abstract][Full Text] [Related]
22. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
Paluri R; Nabell L; Borak S; Peker D
Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
[TBL] [Abstract][Full Text] [Related]
23. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
Haouas H; Haouas S; Uzan G; Hafsia A
Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
[TBL] [Abstract][Full Text] [Related]
24. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Garnache-Ottou F; Vidal C; Biichlé S; Renosi F; Poret E; Pagadoy M; Desmarets M; Roggy A; Seilles E; Soret L; Schillinger F; Puyraimond S; Petrella T; Preudhomme C; Roumier C; MacIntyre EA; Harrivel V; Desbrosses Y; Gruson B; Geneviève F; Thepot S; Drebit Y; Leguay T; Gros FX; Lechevalier N; Saussoy P; Salaun V; Cornet E; Benseddik Z; Veyrat-Masson R; Wagner-Ballon O; Salanoubat C; Maynadié M; Guy J; Caillot D; Jacob MC; Cahn JY; Gressin R; Rose J; Quesnel B; Guerin E; Trimoreau F; Feuillard J; Gourin MP; Plesa A; Baseggio L; Arnoux I; Vey N; Blaise D; Lacroix R; Arnoulet C; Benet B; Dorvaux V; Bret C; Drenou B; Debliquis A; Latger-Cannard V; Bonmati C; Bene MC; Peterlin P; Ticchioni M; Rohrlich PS; Arnaud A; Wickenhauser S; Bardet V; Brechignac S; Papoular B; Raggueneau V; Vargaftig J; Letestu R; Lusina D; Braun T; Foissaud V; Tamburini J; Bennani H; Freynet N; Cordonnier C; Le Garff-Tavernier M; Jacques N; Maloum K; Roos-Weil D; Bouscary D; Asnafi V; Lhermitte L; Suarez F; Lengline E; Féger F; Battipaglia G; Mohty M; Bouyer S; Ghoual O; Dindinaud E; Basle C; Puyade M; Lafon C; Fest T; Roussel M; Cahu X; Bera E; Daliphard S; Jardin F; Campos L; Solly F; Guyotat D; Galoisy AC; Eischen A; Mayeur-Rousse C; Guffroy B; Recher C; Loosveld M; Garnier A; Barlogis V; Rosenthal MA; Brun S; Contentin N; Maury S; Callanan M; Lefebvre C; Maillard N; Okamba P; Ferrand C; Adotevi O; Saas P; Angelot-Delettre F; Binda D; Deconinck E
Blood Adv; 2019 Dec; 3(24):4238-4251. PubMed ID: 31869411
[TBL] [Abstract][Full Text] [Related]
25. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
[TBL] [Abstract][Full Text] [Related]
26. [NT5C2 expression in children with acute leukemia and its clinical significance].
Wang Y; An X; Liu J; Zhang N; Liu Z; Liang S; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2015 Sep; 36(9):748-53. PubMed ID: 26462774
[TBL] [Abstract][Full Text] [Related]
27. Investigation of a novel biomarker, neuropilin-1, and its application for poor prognosis in acute myeloid leukemia patients.
Zhao J; Gu L; Li C; Ma W; Ni Z
Tumour Biol; 2014 Jul; 35(7):6919-24. PubMed ID: 24737589
[TBL] [Abstract][Full Text] [Related]
28. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape.
Zalmaï L; Viailly PJ; Biichle S; Cheok M; Soret L; Angelot-Delettre F; Petrella T; Collonge-Rame MA; Seilles E; Geffroy S; Deconinck E; Daguindau E; Bouyer S; Dindinaud E; Baunin V; Le Garff-Tavernier M; Roos-Weil D; Wagner-Ballon O; Salaun V; Feuillard J; Brun S; Drenou B; Mayeur-Rousse C; Okamba P; Dorvaux V; Tichionni M; Rose J; Rubio MT; Jacob MC; Raggueneau V; Preudhomme C; Saas P; Ferrand C; Adotevi O; Roumier C; Jardin F; Garnache-Ottou F; Renosi F
Haematologica; 2021 Dec; 106(12):3056-3066. PubMed ID: 33054115
[TBL] [Abstract][Full Text] [Related]
29. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
Riaz W; Zhang L; Horna P; Sokol L
Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
[TBL] [Abstract][Full Text] [Related]
30. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Davis K; Sheikh T; Aggarwal N
Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
[TBL] [Abstract][Full Text] [Related]
31. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
32. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
33. LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis.
Ceroi A; Masson D; Roggy A; Roumier C; Chagué C; Gauthier T; Philippe L; Lamarthée B; Angelot-Delettre F; Bonnefoy F; Perruche S; Biichle S; Preudhomme C; Macintyre E; Lagrost L; Garnache-Ottou F; Saas P
Blood; 2016 Dec; 128(23):2694-2707. PubMed ID: 27702801
[TBL] [Abstract][Full Text] [Related]
34. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
[TBL] [Abstract][Full Text] [Related]
35. Role of neuropilin-1 and its expression in Egyptian acute myeloid and acute lymphoid leukemia patients.
Younan S; Elhoseiny S; Hammam A; Gawdat R; El-Wakil M; Fawzy M
Leuk Res; 2012 Feb; 36(2):169-73. PubMed ID: 21978468
[TBL] [Abstract][Full Text] [Related]
36. TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.
Alayed K; Patel KP; Konoplev S; Singh RR; Routbort MJ; Reddy N; Pemmaraju N; Zhang L; Shaikh AA; Aladily TN; Jain N; Luthra R; Medeiros LJ; Khoury JD
Am J Hematol; 2013 Dec; 88(12):1055-61. PubMed ID: 23940084
[TBL] [Abstract][Full Text] [Related]
37. Programmed Death Ligand-1 is Frequently Expressed in Primary Acute Myeloid Leukemia and B-Acute Lymphoblastic Leukemia.
Hamdan SO; Sughayer M; Khader M; Tbakhi A; Khudirat S; Hejazi A; AlRyalat S; Bustami N; Aladily TN
Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443604
[TBL] [Abstract][Full Text] [Related]
38. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.
Virk H; Rana S; Sharma P; Bose PL; Yadav DD; Sachdeva MUS; Varma N; Trehan A; Lad D; Khadwal AR; Malhotra P; Sreedharanunni S
Ann Hematol; 2021 Aug; 100(8):2031-2041. PubMed ID: 34159401
[TBL] [Abstract][Full Text] [Related]
39. Cytogenetic Findings in a Case of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
Tirado CA; Reinartz J; Lapp K; Zhao D; Nguyen AM; Stieglbauer K
J Assoc Genet Technol; 2020; 46(1):5-13. PubMed ID: 32161188
[TBL] [Abstract][Full Text] [Related]
40. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
Cáp J; Babusíková O; Kaiserová E; Jamárik M
Neoplasma; 1998; 45(4):231-6. PubMed ID: 9890666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
